Credit Suisse Starts TriVascular Technologies (TRIV) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Canaccord Genuity Starts TriVascular Technologies (TRIV) at Buy
May 12, 2014 8:10 AM EDTCanaccord Genuity initiated coverage on TriVascular Technologies (NASDAQ: TRIV) with a Buy rating and a price target of $20.00.
For an analyst ratings summary and ratings history on TriVascular Technologies click here. For more ratings news on TriVascular Technologies click here.
Shares of TriVascular Technologies closed at $12.92 yesterday.
... MoreJPMorgan Starts TriVascular Technologies (TRIV) at Overweight
May 12, 2014 8:08 AM EDTJPMorgan initiated coverage on TriVascular Technologies (NASDAQ: TRIV) with an Overweight rating and a price target of $18.00.
For an analyst ratings summary and ratings history on TriVascular Technologies click here. For more ratings news on TriVascular Technologies click here.
Shares of TriVascular Technologies closed at $12.92 yesterday.
... MoreStifel Nicolaus Starts TriVascular Technologies (TRIV) at Buy
May 12, 2014 8:08 AM EDTStifel Nicolaus initiated coverage on TriVascular Technologies (NASDAQ: TRIV) with a Buy rating and a price target of $17.00.
For an analyst ratings summary and ratings history on TriVascular Technologies click here. For more ratings news on TriVascular Technologies click here.
Shares of TriVascular Technologies closed at $12.92 yesterday.
... More